申请人:Johnson Matthey Public Limited Company
公开号:US05350837A1
公开(公告)日:1994-09-27
The ligand L, (R.sup.3)(R.sup.4)(R.sup.5)C--N(R)--C(R.sup.1)(R.sup.2)--(CH.sub.2).sub.n --COOH L where R is hydrogen, hydroxy, alkyl, hydroxyalkyl, or alkylcarboxy, or R and R.sup.1 together may form a mono-, di-, tri-, or tetra-methylene radical, or R and R.sup.3 together may form a mono-, di-, tri-, or tetra-methylene radical, and R.sup.1 and R.sub.2 may be the same or different and are selected from hydrogen, hydroxy, alkyl, hydroxyalkyl, carboxy, alkylcarboxy, alkylamine, alkylthiol, aryl or R.sup.1 and R.sup.2 together may form a tetra- or penta-methylene radical, and R.sup.3 and R.sup.4 and R.sup.5 may be the same or different and are selected from hydrogen, hydroxy, alkyl, hydroxyalkyl, carboxy, alkylcarboxy, provided that at least one of R.sup.3, R.sup.4 and R.sup.5 is hydroxyalkyl, and n is equal to 0, 1 or 2, for example tricine, form useful complexes with .sup.99m Tc, for radiolabelling macromolecules such as monoclonal antibodies.
配体L,(R.sup.3)(R.sup.4)(R.sup.5)C--N(R)--C(R.sup.1)(R.sup.2)--(CH.sub.2).sub.n --COOH L,其中R为氢、羟基、烷基、羟基烷基或烷基羧基,或R和R.sup.1共同形成单、二、三或四亚甲基基团,或R和R.sup.3共同形成单、二、三或四亚甲基基团,而R.sup.1和R.sub.2可以相同也可以不同,选择自氢、羟基、烷基、羟基烷基、羧基、烷基羧基、烷基胺、烷基
硫醇、芳基或R.sup.1和R.sup.2共同形成四亚甲基或五亚甲基基团,而R.sup.3、R.sup.4和R.sup.5可以相同也可以不同,选择自氢、羟基、烷基、羟基烷基、羧基、烷基羧基,只要R.sup.3、R.sup.4和R.sup.5中至少有一个是羟基烷基,n等于0、1或2,例如tricine,与.sup.99m Tc形成有用的复合物,用于放射标记大分子如单克隆
抗体。